piracetam - CISMeF

Preferred Label : piracetam;

MeSH definition : A compound suggested to be both a nootropic and a neuroprotective agent.;

MeSH synonym : pyramem; pyracetam; pirazetam; 2-pyrrolidone-n-acetamide;

CISMeF synonym : azupharma brand of piracetam; merckle brand of piracetam; almirall brand of piracetam; TAD brand of piracetam; hormona brand of piracetam; vedim brand of piracetam; alpharma brand of piracetam; sanofi synthelabo brand of piracetam; UCB brand of piracetam; hexal brand of piracetam; AbZ brand of piracetam; holsten brand of piracetam; rodleben brand of piracetam; riemser brand of piracetam; pfizer brand of piracetam;

DeCS synonym : Normabra n;

MeSH hyponym : axonyl; UCB-6215; geram; avigilen; piracetam AbZ; dinagen; gabacet; piracetrop; cerepar N; ciclofalina; piracebral; cuxabrain; cerebroforte; Memo-Puren; nootropil; sinapsan; Memo Puren; Nootrop; Normabraïn; Nootropyl; Piracetam-RPh; Piracetam RPh; UCB 6215; UCB6215;

MeSH CAS label : 1-Pyrrolidineacetamide, 2-oxo-;

MeSH Related Number : 7491-74-9 (Piracetam);

Registry Number MeSH : 7491-74-9;

Wikipedia link : https://en.wikipedia.org/wiki/Piracetam;

Codes EINECS : 231-312-7;

Is substance : O;

UNII : ZH516LNZ10;

InChIKey : GMZVRMREEHBGGF-UHFFFAOYSA-N;

Details

Origin ID

D010889;

UMLS CUI

C0031977;

ATC code(s)
- piracetam [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
CISMeF manual mappings
- Piracetam adverse reaction (disorder) [SNOMED CT concept]
- piracetam [Substance BNPC]
Currated CISMeF NLP mapping
- Piracetam [ICD-11 Extension code]
- Piracetam [SMS substance]
- Piracetam [NCIt concept]
- Piracetam (substance) [SNOMED CT concept]
- Piracetam poisoning (disorder) [SNOMED CT concept]
Pharmacological action(s)
- neuroprotective agents [MeSH Descriptor]
- nootropic agents [MeSH Descriptor]
Record concept(s)
- Memo-Puren [MeSH concept]
- UCB-6215 [MeSH concept]
- avigilen [MeSH concept]
- axonyl [MeSH concept]
- cerebroforte [MeSH concept]
- cerepar N [MeSH concept]
- ciclofalina [MeSH concept]
- cuxabrain [MeSH concept]
- dinagen [MeSH concept]
- gabacet [MeSH concept]
- geram [MeSH concept]
- nootropil [MeSH concept]
- piracebral [MeSH concept]
- piracetam [MeSH concept]
- piracetam AbZ [MeSH concept]
- piracetrop [MeSH concept]
- sinapsan [MeSH concept]
Related MeSH Supplementary Concept(s)
- 2-thioxo-1-pyrrolidineacetamide [MeSH Supplementary Concept]
- 2-thioxo-1-pyrrolidinethioacetamide [MeSH Supplementary Concept]
- 4-phenylpiracetam [MeSH Supplementary Concept]
- N-phenylpiracetam [MeSH Supplementary Concept]
- S-phenylpiracetam [MeSH Supplementary Concept]
- heparin-piracetam complex [MeSH Supplementary Concept]
- phezam [MeSH Supplementary Concept]
- piracetam hydrazide [MeSH Supplementary Concept]
- piracetam, vinpocetine drug combination [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Piracetam [NCIt concept]
- Piracetam (substance) [SNOMED CT concept]
- Product containing piracetam (medicinal product) [SNOMED CT concept]
- piracetam [ATC Code]
- piracetam [Substance BNPC]
Validated automatic mappings to BTNT
- piracetam [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients